Honest reporting of side effects is essential for the community. This article aggregates the most commonly reported side effects from community experience reports across the most popular peptides.
BPC-157
Side effects are rarely reported. The most common reports are mild injection site reactions (redness, minor swelling) that resolve within hours. A small number of users report vivid dreams or mild nausea. Serious adverse effects are extremely rare in community reports.
Ipamorelin + CJC-1295
The most commonly reported side effect is water retention, particularly in the early weeks of a protocol. Mild tingling in the extremities is also frequently reported. Hunger increase is reported with GHRP-2 and GHRP-6 but rarely with Ipamorelin.
Semaglutide
Nausea is the most commonly reported side effect, affecting the majority of users during the titration phase. Constipation, fatigue, and headache are also frequently reported. Serious adverse effects (pancreatitis, gallbladder issues) are rare but documented — physician supervision is essential.
NAD+ IV
Infusion discomfort (flushing, chest tightness, nausea) is reported by most IV users, particularly at higher doses. These effects are typically transient and resolve during or shortly after the infusion. Slow infusion rates significantly reduce discomfort.
When to Seek Medical Attention
Any severe or unexpected reaction should prompt immediate medical consultation. Physician-supervised protocols through Alukard include ongoing monitoring and direct access to medical guidance if side effects occur.